Life Sciences Tools and Services
Company Overview of ProteinSimple
ProteinSimple develops protein analysis tools for researchers. It offers systems for protein imaging; systems to probe the structure and purity of protein based therapeutics; and systems that provide fresh insight into protein signaling. The company provides NanoPro systems for protein analysis in precious samples, quantify phosphoprotein signaling, and identify phosphoprotein isoforms; iCE systems to measure protein purity, charge heterogeneity protein analysis, method development, evaluate formulation development, and screen cell lines; and micro-flow imaging systems to subvisible particle analysis, quantify protein aggregates, characterize particulates, detect translucent particles, monit...
3040 Oakmead Village Drive
Santa Clara, CA 95051
Founded in 2000
Key Executives for ProteinSimple
Chief Financial Officer and Vice President of Operations
Vice President of Corporate Development
Vice President of Product Development
Director of Product Management
Compensation as of Fiscal Year 2013.
ProteinSimple Key Developments
ProteinSimple Announces Appointment Of Board of Directors
Mar 24 14
ProteinSimple announced the appointments of two independent members of the company's Board of Directors, Mr. Chris van Ingen and Dr. Joe Keegan. Most recently, Keegan served as the CEO of ForteBio where he transformed the company from a startup in 2007 to a fast growing leader in label-free protein analysis. Dr. Keegan currently serves on the Board of Directors of ALDA as Immediate Past Chairman, Advanced Cell Diagnostics, Labcyte Corporation as Chairman, Response Biomedical Corp, Seahorse Bioscience Inc., Stereotaxis Inc. and the San Francisco Opera. Most recently, Chris van Ingen served as President of Agilent Technologies' Bio-Analytical Measurement business, he oversaw the growth of that business from $1 billion to over $2 billion in annual revenues in less than six years.
ProteinSimple Launches Second Generation, High Throughput Simple Western Systems
Jan 13 14
ProteinSimple launched Sally Sue and Peggy Sue, the next generation of high throughput Simple Western instruments. These instruments drive the sensitivity of the current high throughput Simple Western systems to performance levels well beyond any traditional Western. The Simple Western is a Western with none of the hassle. No messy gels, no transfer tanks, no blots, no imaging and no manual analysis. In 2012, ProteinSimple introduced two high throughput instruments that surpassed the throughput of the traditional Western by 50 times. These systems allowed researchers to simply load up to 96 samples, push a button, walk away and come back to fully analyzed, truly quantitative data in less than a day. Sally Sue and Peggy Sue enhance the value of these high throughput systems by delivering at least 10 times the sensitivity of the first generation instruments and require 80% less sample. Both systems separate proteins by size and Peggy Sue can also separate proteins by charge. Together, these systems offer biopharmaceutical researchers the high throughput and the best sensitivity available in an immunoassay-based separation platform.
ProteinSimple Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-16-2014 08:00 AM
Dec 31 13
ProteinSimple Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-16-2014 08:00 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Timothy A. Harkness, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|